Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,908 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

NCT07109219

Conditions
B-cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Iowa City, Iowa, United States
View all 26 locations
View Trial Details
Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Conditions
Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
Locations
  • The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

NCT05181826

Conditions
Blood-Borne Infections, COPD, Cancer, +32 more
Locations
  • Torrance Memorial Physician Network - Cancer Care Redondo Beach, California, United States
  • Allina Health, Virginia Piper Cancer Institute Coon Rapids, Minnesota, United States
  • Virginia Piper Cancer Institute Mercy Hospital-Unity Campus Fridley, Minnesota, United States
  • VPCI Oncology Research Minneapolis, Minnesota, United States
View Trial Details
Recruiting

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

NCT07406360

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Walnut Creek, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 17 locations
View Trial Details

Related conditions